Design and synthesis of 2-N-substituted indazolone derivatives as non-carboxylic acid glycogen synthase activators
摘要:
Glycogen synthase (GS) catalyzes the transfer of glucose residues from UDP-glucose to a glycogen polymer chain, a critical step for glucose storage. Patients with type 2 diabetes normally exhibit low glycogen levels and decreased muscle glucose uptake is the major defect in whole body glucose disposal. Therefore, activating GS may provide a potential approach for the treatment of type 2 diabetes. In order to identify non-carboxylic acids GS activators, we designed and synthesized a series of 2-N-alkyl- and 2-N-aryl-indazolone derivatives and studied their activity in activating human GS. (C) 2013 Elsevier Ltd. All rights reserved.
Design and synthesis of 2-N-substituted indazolone derivatives as non-carboxylic acid glycogen synthase activators
摘要:
Glycogen synthase (GS) catalyzes the transfer of glucose residues from UDP-glucose to a glycogen polymer chain, a critical step for glucose storage. Patients with type 2 diabetes normally exhibit low glycogen levels and decreased muscle glucose uptake is the major defect in whole body glucose disposal. Therefore, activating GS may provide a potential approach for the treatment of type 2 diabetes. In order to identify non-carboxylic acids GS activators, we designed and synthesized a series of 2-N-alkyl- and 2-N-aryl-indazolone derivatives and studied their activity in activating human GS. (C) 2013 Elsevier Ltd. All rights reserved.
INDAZOLONE ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS
申请人:Bolin David Robert
公开号:US20110112147A1
公开(公告)日:2011-05-12
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
[EN] INDAZOLONE DERIVATIVES AS GLYCOGEN SYNTHASE ACTIVATORS<br/>[FR] DÉRIVÉS INDAZOLONE EN TANT QU'ACTIVATEURS DE GLYCOGÈNE SYNTHASE
申请人:HOFFMANN LA ROCHE
公开号:WO2011057993A1
公开(公告)日:2011-05-19
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.